BAIAP2L2 and hepatocellular carcinoma: Furthermore, by survival analysis, we found that high expression of BAIAP2L2 was associated with poor OS and a short PFI in HCC patients, suggesting that reducing the expression of BAIAP2L2 may improve the prognosis of patients with HCC.